Douglas Braunstein’s Hudson Executive Capital Selling Atricure Inc. (ATRC)

Page 2 of 8 – SEC Filing

1
NAMES OF REPORTING PERSON
   Hudson Executive Capital LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a)  ☐
 (b)  ☐
3
SEC USE ONLY
4
SOURCE OF FUNDS
AF
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 ☐
6
CITIZENSHIP OR PLACE OF ORGANIZATION
   Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
0
8
SHARED VOTING POWER
1,882,494
9
SOLE DISPOSITIVE POWER
0
10
SHARED DISPOSITIVE POWER
1,882,494
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,882,494
12
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 ☐
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
4.98%(1)
14
TYPE OF REPORTING PERSON
PN, IA

(1)
The percentage calculations herein are based upon an aggregate of 37,812,869 shares of common stock, par value $.001 per share, of AtriCure, Inc. outstanding as of the completion of AtriCure, Inc.’s offering of common stock on or about October 10, 2018, as reported in AtriCure, Inc.’s prospectus supplement filed pursuant to Rule 424(b)(5) on October 5, 2018.
Follow Atricure Inc. (NASDAQ:ATRC)